Embecta Corp.

XNASHealth care

Last traded price · USD

$6.50

−0.31%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $6.52
Volume: 1
Day's high: —
Day's low: —

In brief

Embecta Corp. is a health care company listed on Nasdaq, valued at about $368M.
Its shares closed at $6.52 on 4 Nov 2026, down 51.8% over the past year.
From India you can buy EMBC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Embecta Corp. (EMBC) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole EMBC share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade EMBC options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +9.6% (SPY −1.6%, XLV +13.5%). 3 months: +82.6% (SPY −0.4%, XLV +15.5%). 1 year: −51.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: EMBC, SPY and XLV · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $6.52 was 12.3% above its 50-day average ($5.81) and 2.8% above its 200-day average ($6.34). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 28 Jan 2026, 194 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
6.2 days to cover short interest
5.9M shares were sold short at the 15 Oct 2026 settlement, 10.4% of the 56.7M shares outstanding; covering them would take 6.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
31% of the way up its 52-week range
Closed at $6.52 on 4 Nov 2026: 56.3% below the 52-week high of $14.91 (12 Nov 2025) and 135.4% above the low of $2.77 (20 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+9.6%

6 months+83.1%

1 year−51.8%

5 years—

Newswire

About

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Website

Notable moves

May 5, 2026
−57.84%
November 26, 2024
+29.77%
May 9, 2024
+37.88%

Newswire

About

Website

Notable moves

May 5, 2026
−57.84%
November 26, 2024
+29.77%
May 9, 2024
+37.88%

Embecta Corp.

XNASHealth care

Last traded price · USD

$6.50

−0.31%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $6.52
Volume: 1
Day's high: —
Day's low: —

In brief

Embecta Corp. is a health care company listed on Nasdaq, valued at about $368M.
Its shares closed at $6.52 on 4 Nov 2026, down 51.8% over the past year.
From India you can buy EMBC in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Embecta Corp. (EMBC) shares from India?

Do I need the price of a whole EMBC share to invest?

How much can I invest in US stocks in a year?

Can I trade EMBC options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +9.6% (SPY −1.6%, XLV +13.5%). 3 months: +82.6% (SPY −0.4%, XLV +15.5%). 1 year: −51.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: EMBC, SPY and XLV · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $6.52 was 12.3% above its 50-day average ($5.81) and 2.8% above its 200-day average ($6.34). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 28 Jan 2026, 194 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
6.2 days to cover short interest
5.9M shares were sold short at the 15 Oct 2026 settlement, 10.4% of the 56.7M shares outstanding; covering them would take 6.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
31% of the way up its 52-week range
Closed at $6.52 on 4 Nov 2026: 56.3% below the 52-week high of $14.91 (12 Nov 2025) and 135.4% above the low of $2.77 (20 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+9.6%

6 months+83.1%

1 year−51.8%

5 years—

Newswire

About

Website

Notable moves

May 5, 2026
−57.84%
November 26, 2024
+29.77%
May 9, 2024
+37.88%

Newswire

About

Website

Notable moves

May 5, 2026
−57.84%
November 26, 2024
+29.77%
May 9, 2024
+37.88%

Embecta Corp.

Embecta Corp. in brief

Behind SPY and its sector fund XLV over 1 year

Above its 50- and 200-day averages

6.2 days to cover short interest

31% of the way up its 52-week range

Embecta Corp.

Embecta Corp. in brief

Behind SPY and its sector fund XLV over 1 year

Above its 50- and 200-day averages

6.2 days to cover short interest

31% of the way up its 52-week range